Compare RNA & OGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RNA | OGS |
|---|---|---|
| Founded | 2012 | 1906 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil/Gas Transmission |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 4.7B |
| IPO Year | 2020 | N/A |
| Metric | RNA | OGS |
|---|---|---|
| Price | $72.39 | $76.96 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 7 |
| Target Price | $69.26 | ★ $84.57 |
| AVG Volume (30 Days) | ★ 2.1M | 420.6K |
| Earning Date | 02-26-2026 | 02-18-2026 |
| Dividend Yield | N/A | ★ 3.46% |
| EPS Growth | N/A | ★ 11.73 |
| EPS | N/A | ★ 4.27 |
| Revenue | $20,868,000.00 | ★ $2,368,759,000.00 |
| Revenue This Year | $57.30 | $23.63 |
| Revenue Next Year | $28.41 | $4.58 |
| P/E Ratio | ★ N/A | $18.11 |
| Revenue Growth | ★ 106.27 | 15.06 |
| 52 Week Low | $21.51 | $66.38 |
| 52 Week High | $72.61 | $83.96 |
| Indicator | RNA | OGS |
|---|---|---|
| Relative Strength Index (RSI) | 73.95 | 41.76 |
| Support Level | $72.04 | $75.29 |
| Resistance Level | $72.47 | $78.49 |
| Average True Range (ATR) | 0.21 | 1.22 |
| MACD | -0.21 | 0.06 |
| Stochastic Oscillator | 63.71 | 48.72 |
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.
ONE Gas Inc is a regulated natural gas utility company. It is involved in the distribution and sale of natural gas to residential, commercial, industrial, and transportation consumers through its network of pipelines and service lines. Almost all of the company's revenue is derived from natural gas sales in the states of Oklahoma, Kansas, and Texas. The company controls considerable market shares in Oklahoma and Kansas.